Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 16, Issue 10, Pages 1089-1100
Publisher
Future Medicine Ltd
Online
2015-07-31
DOI
10.2217/pgs.15.64
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems
- (2014) L J Rasmussen-Torvik et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes
- (2014) Laura G. Stoudenmire et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
- (2013) William J. Canestaro et al.
- Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation
- (2013) J Pink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
- (2013) I. Lisanne Holster et al. GASTROENTEROLOGY
- Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis
- (2013) Joyce H. S. You JOURNAL OF GENERAL INTERNAL MEDICINE
- Supervised Patient Self-Testing of Warfarin Therapy Using an Online System
- (2013) Luke Ryan Elliot Bereznicki et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
- (2013) Stephen E. Kimmel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Genotype-Guided Dosing of Warfarin
- (2013) Munir Pirmohamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
- (2013) Charalampos Kasmeridis et al. PHARMACOECONOMICS
- Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation
- (2013) Joyce H.S. You Pharmacogenetics and Genomics
- Evaluation of Warfarin Management with International Normalized Ratio Self-Testing and Online Remote Monitoring and Management Plus Low-Dose Vitamin K with Genomic Considerations: A Pilot Study
- (2013) Henry I. Bussey et al. PHARMACOTHERAPY
- A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)
- (2012) Jeffrey L. Anderson et al. CIRCULATION
- Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting
- (2012) Seol Young Han et al. JOURNAL OF ELECTROCARDIOLOGY
- Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation
- (2012) Joyce H. S. You et al. PLoS One
- Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
- (2011) Shimoli V. Shah et al. CIRCULATION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
- (2011) Anuraag Kansal et al. THROMBOSIS AND HAEMOSTASIS
- New allele-specific real-time PCR system for warfarin dose genotyping equipped with an automatic interpretative function that allows rapid, accurate, and user-friendly reporting in clinical laboratories
- (2011) Sollip Kim et al. THROMBOSIS RESEARCH
- National Patterns of Risk-Standardized Mortality and Readmission for Acute Myocardial Infarction and Heart Failure
- (2010) Susannah M. Bernheim et al.
- Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping
- (2010) Carleta B. Maurice et al. CLINICA CHIMICA ACTA
- Warfarin Genotyping Reduces Hospitalization Rates
- (2010) Robert S. Epstein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
- (2010) Joyce H. S. You et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study
- (2009) Y.-K. KIM et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: Results from the Treating to New Targets (TNT) Trial
- (2008) Daniel B. Mark et al. AMERICAN HEART JOURNAL
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
- (2008) Stuart J. Connolly et al. CIRCULATION
- Effect of aspirin and warfarin on early survival after intracerebral haemorrhage
- (2008) H. C. Hanger et al. JOURNAL OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More